Corevalve evolut pro

Manufactured by Medtronic

Sourced in United States

The CoreValve™ Evolut™ Pro is a transcatheter aortic valve replacement (TAVR) system designed for the treatment of severe aortic stenosis. It is a minimally invasive device used to replace a patient's diseased aortic valve without open-heart surgery.

Automatically generated - may contain errors

Lab products found in correlation

Corevalve evolut r, by Medtronic (2 mentions)

2 protocols using corevalve evolut pro

Transfemoral TAVR with Evolut Devices

Check if the same lab product or an alternative is used in the 5 most similar protocols

All 303 patients in this study underwent TAVR using transfemoral access with second (CoreValve™ Evolut™ R; Medtronic Inc., Minneapolis, MN, USA) or third (CoreValve™ Evolut™ Pro; Medtronic Inc., Minneapolis, MN, USA) generation devices. The procedure was performed as previously described [12 (link)].

Boxhammer E., Dienhart C., Kletzer J., Ramsauer S., Kopp K., Prinz E., Wintersteller W., Blessberger H., Hammerer M., Steinwender C., Lichtenauer M, & Hoppe U.C. (2023). Elevated systolic pulmonary artery pressure is a substantial predictor of increased mortality after transcatheter aortic valve replacement in males, not in females. Clinical Research in Cardiology, 113(1), 138-155.

+ Open protocol

+ Expand

Transfemoral TAVR Using Second and Third Generation Devices

Check if the same lab product or an alternative is used in the 5 most similar protocols

Indications for TAVR were assessed by a multidisciplinary heart team consisting of cardiologists and cardiologic surgeons. The TAVR procedure was performed as previously described [12 (link)]. All 179 patients received TAVR via transfemoral access with TAVR devices of second generation (CoreValve™ Evolut™ R; Medtronic Inc., Minneapolis, MN, USA) or third generation (CoreValve™ Evolut™ Pro; Medtronic Inc., Minneapolis, MN, USA).

Hecht S., Boxhammer E., Kaufmann R., Scharinger B., Reiter C., Kammler J., Kellermair J., Hammerer M., Blessberger H., Steinwender C., Hoppe U.C., Hergan K, & Lichtenauer M. (2022). CT-Diagnosed Sarcopenia and Cardiovascular Biomarkers in Patients Undergoing Transcatheter Aortic Valve Replacement: Is It Possible to Predict Muscle Loss Based on Laboratory Tests?—A Multicentric Retrospective Analysis. Journal of Personalized Medicine, 12(9), 1453.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!